Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cellular Immunology

• Publication date

  2016-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellimm.2016.07.004PMID 27444130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters

  2016cited by this paper
• IL‐17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani

  2016cited by this paper
• Different Leishmania Species Drive Distinct Neutrophil Functions.

  2016cited by this paper
• Successful Therapy of Murine Visceral Leishmaniasis with Astrakurkurone, a Triterpene Isolated from the Mushroom Astraeus hygrometricus, Involves the Induction of Protective Cell-Mediated Immunity and TLR9

  2016cited by this paper
• SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKCβ.

  2016cited by this paper
• IL-17A–Producing γδ T Cells Suppress Early Control of Parasite Growth by Monocytes in the Liver

  2015cited by this paper
• Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation.

  2015influential reference
• Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis

  2015cited by this paper
• Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection.

  2015cited by this paper
• Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge

  2014cited by this paper
• Genetically Modified Organisms and Visceral Leishmaniasis

  2014cited by this paper
• Characterization of Cross-Protection by Genetically Modified Live-Attenuated Leishmania donovani Parasites against Leishmania mexicana

  2014cited by this paper
• Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.

  2014cited by this paper
• Immune Regulation during Chronic Visceral Leishmaniasis

  2014cited by this paper
• Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications

  2014cited by this paper
• IL-17-Expressing CD4+ and CD8+ T Lymphocytes in Human Toxoplasmosis

  2014cited by this paper
• Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis

  2014cited by this paper
• IL-17 Mediates Immunopathology in the Absence of IL-10 Following Leishmania major Infection

  2013cited by this paper
• Interleukin-17-dependent CXCL-13 mediates mucosal vaccine-induced immunity against tuberculosis

  2013cited by this paper
• Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions

  2013cited by this paper
• Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

  2013cited by this paper
• Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB/c Mice

  2013cited by this paper
• CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.

  2013cited by this paper
• Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines.

  2013influential reference
• How Cytokine Networks Fuel Inflammation: Interleukin-17 and a tale of two autoimmune diseases

  2013cited by this paper
• Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells

  2013cited by this paper
• Evidence for Involvement of Th17 Type Responses in Post Kala Azar Dermal Leishmaniasis (PKDL)

  2012cited by this paper
• Evaluation of Recombinant Leishmania Polyprotein Plus Glucopyranosyl Lipid A Stable Emulsion Vaccines against Sand Fly-Transmitted Leishmania major in C57BL/6 Mice

  2012cited by this paper
• Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates

  2012cited by this paper
• American Tegumentary Leishmaniasis: Cytokines and Nitric Oxide in Active Disease and After Clinical Cure, With or Without Chemotherapy

  2012cited by this paper
• The influence of early neutrophil-Leishmania interactions on the host immune response to infection

  2012cited by this paper
• Natural killer cells in experimental and human leishmaniasis

  2012cited by this paper
• Th17 cells confer long term adaptive immunity to oral mucosal Candida albicans infections

  2012cited by this paper
• Th17 cells in immunity to Candida albicans.

  2012influential reference
• Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites

  2011cited by this paper
• IL‐17 and Regulatory Cytokines (IL‐10 and IL‐27) in L. braziliensis Infection

  2011cited by this paper
• Langerhans cells are negative regulators of the anti-Leishmania response

  2011cited by this paper
• Leishmaniasis: complexity at the host–pathogen interface

  2011influential reference
• Dissecting the human immunologic memory for pathogens

  2011cited by this paper
• IL-27 and IL-21 Are Associated with T Cell IL-10 Responses in Human Visceral Leishmaniasis

  2011cited by this paper
• Immunological mechanisms of vaccination

  2011cited by this paper
• IL-17 Is Necessary for Host Protection against Acute-Phase Trypanosoma cruzi Infection

  2010cited by this paper
• Immunological Perspectives of Leishmaniasis

  2010cited by this paper
• Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.

  2009cited by this paper
• Intracellular Replication-Deficient Leishmania donovani Induces Long Lasting Protective Immunity against Visceral Leishmaniasis

  2009cited by this paper
• Interleukin 17 production among patients with American cutaneous leishmaniasis.

  2009cited by this paper
• IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani.

  2009influential reference
• The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo

  2009cited by this paper
• IL-27 Regulates IL-10 and IL-17 from CD4+ Cells in Nonhealing Leishmania major Infection1

  2009cited by this paper
• Interleukin‐17 in host defence against bacterial, mycobacterial and fungal pathogens

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• IL-17 Promotes Progression of Cutaneous Leishmaniasis in Susceptible Mice1

  2009influential reference
• Immunological decision‐making: how does the immune system decide to mount a helper T‐cell response?

  2008influential reference
• In Vivo Imaging Reveals an Essential Role for Neutrophils in Leishmaniasis Transmitted by Sand Flies

  2008cited by this paper
• TH-17 cells in the circle of immunity and autoimmunity

  2007cited by this paper
• Neutrophils Contribute to Development of a Protective Immune Response during Onset of Infection with Leishmania donovani

  2007cited by this paper
• IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

  2007cited by this paper
• Th17: the third member of the effector T cell trilogy.

  2007influential reference
• Balancing immunity and pathology in visceral leishmaniasis

  2007cited by this paper
• Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation.

  2007cited by this paper
• Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity.

  2007cited by this paper
• Neutrophils Activate Macrophages for Intracellular Killing of Leishmania major through Recruitment of TLR4 by Neutrophil Elastase1

  2007cited by this paper
• Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity

  2007cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• Phlebotomine sand flies and Leishmania parasites: friends or foes?

  2006cited by this paper
• Advances in leishmaniasis.

  2005cited by this paper
• Visceral Leishmaniasis: New Health Tools Are Needed

  2005cited by this paper
• Cutting Edge: Neutrophil Granulocyte Serves as a Vector for Leishmania Entry into Macrophages1

  2004cited by this paper
• Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.

  2004influential reference
• Interleukin-17 family members and inflammation.

  2004cited by this paper
• Both Interleukin-4 (IL-4) and IL-4 Receptor α Signaling Contribute to the Development of Hepatic Granulomas with Optimal Antileishmanial Activity

  2003cited by this paper
• Further checkpoints in Th1 development.

  2002cited by this paper
• Reduced Infectivity of a Leishmania donovani Biopterin Transporter Genetic Mutant and Its Use as an Attenuated Strain for Vaccination

  2002cited by this paper
• CD95 is required for the early control of parasite burden in the liver of Leishmania donovani‐infected mice

  2001cited by this paper
• Tissue granuloma structure‐function in experimental visceral leishmaniasis

  2001cited by this paper
• Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense

  2001influential reference
• Signaling and transcription in T helper development.

  2000cited by this paper
• Intracellular Antimicrobial Activity in the Absence of Interferon-γ: Effect of Interleukin-12 in Experimental Visceral Leishmaniasis in Interferon-γ Gene-disrupted Mice

  1997cited by this paper
• Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.

  1995cited by this paper
• Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major

  1994cited by this paper
• Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host

  1993cited by this paper
• Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells

  1993cited by this paper
• Role and effect of IL-2 in experimental visceral leishmaniasis.

  1993cited by this paper
• Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.

  1989cited by this paper
• Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

  1985cited by this paper
• Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis

  1983cited by this paper

• An Overview of the Factors Related to Leishmania Vaccine Development

  2026cites this paper
• Mechanistic evidence for dibutyl phthalate as an environmental trigger for inflammatory bowel disease

  2026cites this paper
• Improving reproducibility and translational potential of mouse models: lessons from studying leishmaniasis

  2025cites this paper
• Toxoplasma gondii non-archetypal strain induces lung inflammation during acute and early chronic infection in mice

  2025cites this paper
• Serum Concentrations of Th1, Th2 and Treg‐Associated Cytokines in Patients With Ocular Toxoplasmosis

  2025cites this paper
• Synthesis, Biological Evaluation, Molecular Dynamics, and QM-MM Calculation of Spiro-Acridine Derivatives Against Leishmaniasis

  2025cites this paper
• Application of the Sponge Model Implants in the Study of Vaccine Memory in Mice Previously Immunized with LBSap

  2024cites this paper
• Leishmania vaccine development: A comprehensive review.

  2024cites this paper
• Investigation of Tongxie-Yaofang formula in treating ulcerative colitis based on network pharmacology via regulating MAPK/AKT signaling pathway

  2024cites this paper
• An elevated level of interleukin-17A in a Senegalese malaria cohort is associated with rs8193038 IL-17A genetic variant

  2024cites this paper
• Chemokines Signature and T Cell Dynamics in Leishmaniasis: Molecular Insight and Therapeutic Application

  2024cites this paper
• Autophagy induced macrophages by α-alumina(α-AL2O3) conjugated cysteine peptidase, enhances the cytotoxic activity of CD8+ T lymphocytes against Leishmania major

  2023cites this paper
• Elucidating the role played by bone marrow in visceral leishmaniasis

  2023cites this paper
• Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis

  2023cites this paper
• Leishmanicidal and immunomodulatory properties of Brazilian green propolis extract (EPP-AF®) and a gel formulation in a pre-clinical model

  2023cites this paper
• Central and Effector Memory Human CD4+ and CD8+ T Cells during Cutaneous Leishmaniasis and after In Vitro Stimulation with Leishmania (Viannia) braziliensis Epitopes

  2023cites this paper
• Solidagenone in vivo leishmanicidal activity acting in tissue repair response, and immunomodulatory capacity in Leishmania amazonensis.

  2022cites this paper
• Decoding systems immunological model of sphingolipids with IL-6/IL-17/IL-23 axes in L. major infection.

  2022cites this paper
• Visceral Leishmaniasis after Anti-Interleukin 17A (IL-17A) Therapy in a Patient Affected by Psoriatic Arthritis

  2022influential citation
• Immune Responses in Leishmaniasis: An Overview

  2022cites this paper
• Multiparametric analysis of host and parasite elements in new world tegumentary leishmaniasis

  2022cites this paper
• Expression Profile of Genes Related to the Th17 Pathway in Macrophages Infected by Leishmania major and Leishmania amazonensis: The Use of Gene Regulatory Networks in Modeling This Pathway

  2022cites this paper
• Unwelcome prevalence of leishmaniasis with several other infectious diseases.

  2022cites this paper
• Exploring the paradox of defense between host and Leishmania parasite.

  2021cites this paper
• Immunization With a DNA Vaccine Encoding the Toxoplasma gondii’ s GRA39 Prolongs Survival and Reduce Brain Cyst Formation in a Murine Model

  2021cites this paper
• Microbiota instruct IL-17A-producing innate lymphoid cells to promote skin inflammation in cutaneous leishmaniasis

  2021cites this paper
• Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis

  2021cites this paper
• Journal of Hard Tissue Biology Interferon-gamma and Interleukin 17 patterns in patients infected with L. major : Early dermal lesions

  2021cites this paper
• Protective and Pathogenic Immune Responses to Cutaneous Leishmaniasis

  2021cites this paper
• Protective and Pathogenic Immune Responses to Cutaneous Leishmaniasis

  2021cites this paper
• Evaluation of systemic immunity in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi

  2021cites this paper
• Involvement of the Inflammasome and Th17 Cells in Skin Lesions of Human Cutaneous Leishmaniasis Caused by Leishmania (Viannia) panamensis

  2020cites this paper
• Cytokine Milieu in Infectious Disease: A Sword or a Boon?

  2020cites this paper
• Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice

  2020cites this paper
• Immune Profile of the Nasal Mucosa in Patients with Cutaneous Leishmaniasis

  2020cites this paper
• Combination of Mycobacterium indicus pranii and Heat-Induced Promastigotes Cures Drug-Resistant Leishmania Infection: Critical Role of Interleukin-6-Producing Classical Dendritic Cells

  2020cites this paper
• Th17 lymphocytes in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi in Central America

  2020cites this paper
• A natural cell-penetrating nanopeptide combined with pentavalent antimonial as experimental therapy against cutaneous leishmaniasis.

  2020cites this paper
• Treatment effects on IL‐9+CD4+ T cells and the cytokines influencing IL‐9 production in paediatric visceral leishmaniasis

  2020cites this paper
• Cytokine profile in Leishmania-positive blood donors

  2020cites this paper
• Serum levels of CC chemokine ligands in cutaneous leishmaniasis patients

  2020cites this paper
• Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: A new promising vaccine against visceral leishmaniasis.

  2020cites this paper
• Goat γδ T cell subpopulations defined by WC1 expression, responses to pathogens and cytokine production.

  2020cites this paper
• The role of interleukin-32 in infections caused by New World Leishmania species and identification of novel treatment strategies

  2019cites this paper
• 1061-1070 Shirian S.pmd

  2019cites this paper
• Organization of the Skin Immune System and Compartmentalized Immune Responses in Infectious Diseases

  2019cites this paper
• Immune profiling of saliva in patients with and without dental caries

  2019cites this paper
• Investigating immune responses to parasites using transgenesis

  2019cites this paper
• Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis

  2019cites this paper
• Coinfection with Leishmania major and Staphylococcus aureus enhances the pathologic responses to both microbes through a pathway involving IL-17A

  2019cites this paper
• Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice

  2018cites this paper
• Interleukin-17A (IL-17A) worsens severe murine respiratory mycoplasma disease

  2018influential citation
• Leishmania treatment and prevention: Natural and synthesized drugs.

  2018cites this paper
• A Leishmania hypothetical protein‐containing liposome‐based formulation is highly immunogenic and induces protection against visceral leishmaniasis

  2018cites this paper
• Immune Mediators against Toxoplasma Gondii during Reactivation of Toxoplasmic Retinochoroiditis

  2018cites this paper
• Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis

  2018cites this paper
• The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis

  2018cites this paper
• Dectin-1 Positive Dendritic Cells Expand after Infection with Leishmania major Parasites and Represent Promising Targets for Vaccine Development

  2018cites this paper
• Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.

  2018cites this paper
• Live Attenuated Leishmania donovani Centrin Gene–Deleted Parasites Induce IL-23–Dependent IL-17–Protective Immune Response against Visceral Leishmaniasis in a Murine Model

  2018cites this paper
• Pathophysiology of Leishmania Infection during Pregnancy.

  2017cites this paper
• CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.

  2017cites this paper
• Wound healing in cutaneous leishmaniasis: A double edged sword of IL-10 and TGF-β.

  2017cites this paper
• Evaluation of a Major Surface Antigen of Babesia microti Merozoites as a Vaccine Candidate against Babesia Infection

  2017cites this paper
• Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis

  2017cites this paper
• Overview of Leishmaniasis with Special Emphasis on Kala-azar in South Asia

  2017cites this paper
• Regulating Immune Mediated Pathology In Cutaneous Leishmaniasis: Roles For Il-22 And Skin Microbiota

  2017cites this paper
• Pharmaco- and immunotherapeutic strategies for the topical treatment of cutaneous leishmaniasis

  2017cites this paper
• The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis

  2017cites this paper
• Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review

  2016cites this paper
• Investigations into the regulation of immune memory resilience

  2016influential citation
• Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions

  2016cites this paper